Filtered By:
Vaccination: Cancer Vaccines
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 7502 results found since Jan 2013.
Subacute thyroiditis after SARS-Cov2 vaccination: A review of the cases being described and personal experience
Conclusions. In times of pandemics and the resulting vaccination, new rapidly occurring sonographic changes in the thyroid gland should be revaluated after 2-3 weeks, or recommended to undergo a fine-needle biopsy, in order to avoid unnecessary surgical interventions.PMID:35843718 | DOI:10.2478/enr-2022-0024
Source: Endocrine Regulations - July 17, 2022 Category: Endocrinology Authors: Costanza Chiapponi Michael Faust Matthias Schmidt Michael Thomas Anne Maria Schultheis Baki Akgul Hakan Alakus Source Type: research
Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations
CONCLUSIONS: Despite evidence obtained from in vitro studies, and some epidemiological and clinical evidence, more robust evidence of in vivo efficacy is still needed to justify the use of BCG in clinical practice, in addition to what is recommended by the National Immunization Program for TB prevention and bladder cancer treatment.PMID:36309066 | DOI:10.1016/j.jped.2022.09.002
Source: Cancer Control - October 29, 2022 Category: Cancer & Oncology Authors: Ekaterini Goudouris Carolina Sanchez Aranda Dirceu Sol é Source Type: research
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
Nat Cancer. 2022 Dec 29. doi: 10.1038/s43018-022-00503-w. Online ahead of print.ABSTRACTPatients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines less effective and treatment options are scarce. Randomized trials using convalescent plasma are missing for high-risk patients. Here, we performed a randomized, open-label, multicenter trial ( https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001632-10/DE ) in hospitalized patients with severe...
Source: Cancer Control - December 29, 2022 Category: Cancer & Oncology Authors: Claudia M Denkinger Maike Janssen Ulrike Sch äkel Julia Gall Albrecht Leo Patrick Stelmach Stefan F Weber Johannes Krisam Lukas Baumann Jacek Stermann Uta Merle Markus A Weigand Christian Nusshag Lars Bullinger Jens-Florian Schrezenmeier Martin Bornh äu Source Type: research
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis
CONCLUSION: Cytotoxic therapy for solid cancer may portend poor immune response following 2 doses of COVID-19 vaccines suggesting a need for booster doses in these patients. Immunotherapy and targeted therapy are likely to be associated with seropositive status, and thus can be considered as an alternative to cytotoxic agents in cases where both therapies are equally efficacious.PMID:36792435 | DOI:10.1016/j.vaccine.2023.01.072
Source: Vaccine - February 15, 2023 Category: Allergy & Immunology Authors: Durgesh Wankhede Sandeep Grover Paul Hofman Source Type: research
The immunopeptidome from a genomic perspective: Establishing the non-canonical landscape of MHC class I-associated peptides
Cancer Immunol Res. 2023 Mar 24:CIR-22-0621. doi: 10.1158/2326-6066.CIR-22-0621. Online ahead of print.ABSTRACTTumor antigens can emerge through multiple mechanisms, including translation of non-coding genomic regions. This non-canonical category of antigens has recently gained attention; however, our understanding of how they recur within and between cancer types is still in its infancy. Therefore, we developed a proteogenomic pipeline based on deep learning de novo mass spectrometry to enable the discovery of non-canonical MHC-associated peptides (ncMAPs) from non-coding regions. Considering that the emergence of tumor a...
Source: Cell Research - March 24, 2023 Category: Cytology Authors: Georges Bedran Hans-Christof Gasser Kenneth Weke Tongjie Wang Dominika Bedran Alexander Laird Christophe Battail Fabio Massimo Zanzotto Catia Pesquita H åkan Axelson Ajitha Rajan David J Harrison Aleksander Palkowski Maciej Pawlik Maciej Parys J Robert O Source Type: research
Project ECHO for Cancer Care: a Scoping Review of Provider Outcome Evaluations
J Cancer Educ. 2023 Mar 31. doi: 10.1007/s13187-023-02292-x. Online ahead of print.ABSTRACTThe Project ECHO model of telementoring has been used for the past 10 years to expand access to specialized cancer care. This scoping review identifies evidence for the model's ability to improve provider outcomes, synthesizing findings from existing studies within Moore et al.'s (2009) framework for continuing medical education outcomes. We search two large research databases and a collection maintained by Project ECHO staff for articles that focus on cancer ECHO programs, involve primary data collection, and were published between ...
Source: Cancer Control - March 31, 2023 Category: Cancer & Oncology Authors: Sanjeev Arora Heidi Rishel Brakey Jessica L Jones Nancy Hood Jesus E Fuentes Lucca Cirolia Source Type: research
Type-I like metalloproteinase in the venom of the West African saw-scaled carpet viper (Echis ocellatus) has anti-trypanosomal activity against African trypanosomes
Toxicon. 2023 Apr 29:107138. doi: 10.1016/j.toxicon.2023.107138. Online ahead of print.ABSTRACTAfrican trypanosomiasis is an infectious disease caused by hemoparasites of the genus Trypanosoma and remains a major health problem in Africa - killing around 4000 people and animals worth an estimated $5 billion, annually. The absence of a vaccine and satisfactory drug against African trypanosomiasis (AT) necessitates the continued search for new chemotherapy options. Owing to the rich biochemical diversity in snake venom, it has recently become a source of therapeutic peptides that are being explored for the development of nov...
Source: Toxicon - May 1, 2023 Category: Toxicology Authors: Ameh Ilu Mathias A Chia Thais R Cataldi Carlos A Labate Godwin U Ebiloma Peter O Yusuf Mohammed N Shuaibu Emmanuel O Balogun Source Type: research
